机构:[1]Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[2]Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[3]Institute of High Performance Computing (IHPC), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore[4]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore[5]Ophthalmology & Visual Sciences Academic Clinical Programme (EYE ACP), Duke-NUS Medical School, Singapore, Singapore[6]Ophthalmology and Visual Science Key Lab, Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, BeijingBeijing, China研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[7]Rothschild Foundation Hospital, Institut Français de Myopie, Paris, France[8]Key Laboratory of Biomechanics and Mechanobiology, Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China[9]Saw Swee Hock School of Public Health, National University of Singaporeand, National University Health System, Singapore, Singapore[10]Duke-NUS Medical School, Singapore, Singapore[11]Precision Health Research, Singapore, Singapore[12]Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
ObjectiveDiabetes and hypertension pose significant health risks, especially when poorly managed. Retinal evaluation though fundus photography can provide non-invasive assessment of these diseases, yet prior studies focused on disease presence, overlooking control statuses. This study evaluated vision transformer (ViT)-based models for assessing the presence and control statuses of diabetes and hypertension from retinal images.MethodsViT-based models with ResNet-50 for patch projection were trained on images from the UK Biobank (n = 113,713) and Singapore Epidemiology of Eye Diseases study (n = 17,783), and externally validated on the Singapore Prospective Study Programme (n = 7,793) and the Beijing Eye Study (n = 6064). Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC) for multiple tasks: detecting disease, identifying poorly controlled and well-controlled cases, distinguishing between poorly and well-controlled cases, and detecting pre-diabetes or pre-hypertension.ResultsThe models demonstrated strong performance in detecting disease presence, with AUROC values of 0.820 for diabetes and 0.781 for hypertension in internal testing. External validation showed AUROCs ranging from 0.635 to 0.755 for diabetes, and 0.727 to 0.832 for hypertension. For identifying poorly controlled cases, the performance remained high with AUROCs of 0.871 (internal) and 0.655-0.851 (external) for diabetes, and 0.853 (internal) and 0.792-0.915 (external) for hypertension. Detection of well-controlled cases also yielded promising results for diabetes (0.802 [internal]; 0.675-0.838 [external]), and hypertension (0.740 [internal] and 0.675-0.807 [external]). In distinguishing between poorly and well-controlled disease, AUROCs were more modest with 0.630 (internal) and 0.512-0.547 (external) for diabetes, and 0.651 (internal) and 0.639-0.683 (external) for hypertension. For pre-disease detection, the models achieved AUROCs of 0.746 (internal) and 0.523-0.590 (external) for pre-diabetes, and 0.669 (internal) and 0.645-0.679 (external) for pre-hypertension.ConclusionViT-based models show promise in classifying the presence and control statuses of diabetes and hypertension from retinal images. These findings support the potential of retinal imaging as a tool in primary care for opportunistic detection of diabetes and hypertension, risk stratification, and individualised treatment planning. Further validation in diverse clinical settings is warranted to confirm practical utility.
基金:
the Agency for Science, Technology and Research (A*STAR) under its RIE2020 Health and Biomedical Sciences (HBMS) Industry Alignment Fund Pre-Positioning (IAF-PP,Grant Number: H20c6a0031).
第一作者机构:[1]Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[2]Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
共同第一作者:
通讯作者:
通讯机构:[1]Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[2]Centre for Innovation and Precision Eye Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[4]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore[5]Ophthalmology & Visual Sciences Academic Clinical Programme (EYE ACP), Duke-NUS Medical School, Singapore, Singapore
推荐引用方式(GB/T 7714):
Pushpanathan Krithi,Bai Yang,Lei Xiaofeng,et al.Vision transformer-based stratification of pre/diabetic and pre/hypertensive patients from retinal photographs for 3PM applications[J].EPMA JOURNAL.2025,doi:10.1007/s13167-025-00412-9.
APA:
Pushpanathan, Krithi,Bai, Yang,Lei, Xiaofeng,Goh, Jocelyn Hui Lin,Xue, Can Can...&Tham, Yih-Chung.(2025).Vision transformer-based stratification of pre/diabetic and pre/hypertensive patients from retinal photographs for 3PM applications.EPMA JOURNAL,,
MLA:
Pushpanathan, Krithi,et al."Vision transformer-based stratification of pre/diabetic and pre/hypertensive patients from retinal photographs for 3PM applications".EPMA JOURNAL .(2025)